FLOW-CYTOMETRY CHARACTERIZATION OF CD34+ CELLS IN BONE-MARROW, CYTAPHERESIS PRODUCTS, AND CORD BLOOD AT BIRTH

被引:10
作者
SOVALAT, H [1 ]
LIANG, H [1 ]
WUNDER, E [1 ]
HENON, P [1 ]
机构
[1] MED UNIV SHANGHAI 2, XIN HUA HOP, SHANGHAI, PEOPLES R CHINA
来源
INTERNATIONAL JOURNAL OF CELL CLONING | 1992年 / 10卷
关键词
FLOW CYTOMETRY; BONE MARROW; CYTAPHERESIS PRODUCTS; UMBILICAL CORD BLOOD; CD34+ CELLS; DIFFERENTIATION; LINEAGE COMMITMENT;
D O I
10.1002/stem.5530100708
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The average content of MNC fractions in CD34+ cells was found to be 1.16 % in normal bone marrow, (BM ; n = 10), 0.90 % in cytapheresis products after mobilization with HD cytostatics (CP ; n = 22), and 0.73 % in umbilical cord blood at birth (UB ; n = 7). In each group the size of the lineage free subfraction of CD34+ cell was determined by use of the MoAb anti CD38, which is absent in uncommitted early precursors. This minor subpopulation shows differences in all three products (5.8 % in CP vs 12 % in UB and 19.4 % in BM). Significant differences exist, if the relative size of subpopulations being committed to the different lineages are compared; for this purpose double immunofluorescence was performed with the MoAb CD71, CD33, CD10 and CD5, which are thought to be lineage specific in hematopoietic cells. The erythroid progenitors were prevalent in CP and UB (80 % and 72.2 %) and lower in BM (43.8 %); also the myeloid marker was more frequent in CP and UB than in BM (68.9 % and 69.1 % vs 32.9 %). B-cell lineage was also more frequent in CP and UB (66.7 % and 77 %) than in BM (32.4 %), as was T-cell lineage (45.4 % and 42 % vs 11.4 %). These results suggest, that circulating hematopoietic cells tend to be committed at a higher degree than those found in bone marrow.
引用
收藏
页码:20 / 22
页数:3
相关论文
共 50 条
[41]   THE INFLUENCE OF 4-DEGREES-C STORAGE ON PROLIFERATIVE POTENTIAL OF HUMAN BONE-MARROW CD34+ CELLS - TRANSPLANTOLOGICAL IMPLICATIONS [J].
RATAJCZAK, MZ ;
SKORSKI, T ;
KUCZYNSKI, WI ;
RATAJCZAK, J .
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 1993, 31 (03) :109-112
[42]   ENRICHMENT OF BONE-MARROW AND BLOOD PROGENITOR (CD34(+)) CELLS BY DENSITY GRADIENTS WITH SUFFICIENT YIELDS FOR TRANSPLANTATION [J].
SCHRIBER, JR ;
DEJBAKHSHJONES, S ;
KUSNIERZGLAZ, CR ;
GINZTON, N ;
STILL, B ;
NEGRIN, RS ;
GREENBERG, P ;
STROBER, S .
EXPERIMENTAL HEMATOLOGY, 1995, 23 (09) :1024-1029
[43]   CD271 as a Marker for Mesenchymal Stem Cells in Bone Marrow versus Umbilical Cord Blood [J].
Watson, J. Tracy ;
Foo, Teresa ;
Wu, Jin ;
Moed, Berton R. ;
Thorpe, Margaret ;
Schon, Lew ;
Zhang, Zijun .
CELLS TISSUES ORGANS, 2013, 197 (06) :496-504
[44]   Two CD34+ stem cells from umbilical cord blood enrichment methods [J].
Pafumi, C ;
Bosco, P ;
Cavallaro, A ;
Farina, M ;
Leonardi, I ;
Pernicone, G ;
Bandiera, S ;
Russo, A ;
Giardina, P ;
Chiarenza, M ;
Calogero, AE .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2002, 19 (04) :239-245
[45]   Effect of testosterone and hypoxia on the expansion of umbilical cord blood CD34+ cells in vitro [J].
Zhou, Liping ;
Zhang, Xiaowei ;
Zhou, Panpan ;
Li, Xue ;
Xu, Xuejing ;
Shi, Qing ;
Li, Dong ;
Ju, Xiuli .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (05) :4467-4475
[46]   COMPARISON OF PURITY AND ENRICHMENT OF CD34(+) CELLS FROM BONE-MARROW, UMBILICAL-CORD AND PERIPHERAL-BLOOD (PRIMED FOR APHERESIS) USING 5 SEPARATION SYSTEMS [J].
DEWYNTER, EA ;
COUTINHO, LH ;
PEI, X ;
MARSH, JCW ;
HOWS, J ;
LUFT, T ;
TESTA, NG .
STEM CELLS, 1995, 13 (05) :524-532
[47]   Distinct Phenotypic and Molecular Characteristics of CD34- and CD34+ Hematopoietic Stem/Progenitor Cell Subsets in Cord Blood and Bone Marrow Samples: Implications for Clinical Applications [J].
Gaafar, Ameera ;
Hamza, Fatheia Nabeil ;
Yousif, Rama ;
Shinwari, Zakia ;
Alotaibi, Aminah Ghazi ;
Iqniebi, Alia ;
Al-Hussein, Khalid ;
Al-Mazrou, Amer ;
Manogaran, Pulicat Subramanian ;
Elhassan, Tusneem ;
Marquez-Mendez, Marcela ;
Aljurf, Mahmood ;
Al-Humaidan, Hind ;
Alaiya, Ayodele .
DIAGNOSTICS, 2025, 15 (04)
[48]   Human cord blood long-term engrafting cells are CD34+ CD38− [J].
F Ishikawa ;
A G Livingston ;
H Minamiguchi ;
J R Wingard ;
M Ogawa .
Leukemia, 2003, 17 :960-964
[49]   Human cord blood long-term engrafting cells are CD34+ CD38- [J].
Ishikawa, F ;
Livingston, AG ;
Minamiguchi, H ;
Wingard, JR ;
Ogawa, M .
LEUKEMIA, 2003, 17 (05) :960-964
[50]   Flow Cytometric Enumeration of Peripheral Blood CD34+ Cells Predicts Bone Marrow Pathology in Patients with Less Than 1% Blasts by Manual Count [J].
Jelic, Tomislav M. ;
Estalilla, Oscar C. ;
Vos, Jeffrey A. ;
Harvey, Gary ;
Stricker, Caitlin J. ;
Adelanwa, Ayodele O. ;
Khalid, Ahmed A. ;
Plata, Milton J. .
JOURNAL OF BLOOD MEDICINE, 2023, 14 :519-535